Legal & General Group
IGMS

Legal & General Group’s IGM Biosciences IGMS Stock Holding History

Legal & General Group’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,746
Closed -$2.02K – 3471
2025
Q1 		$2.02K Hold
1,746
– – ﹤0.01% 3353
2024
Q4 		$10.7K Hold
1,746
– – ﹤0.01% 3241
2024
Q3 		$28.9K Buy
1,746
+385
+28% +$4.22K ﹤0.01% 2909
2024
Q2 		$9.35K Buy
1,361
+338
+33% +$2.89K ﹤0.01% 3314
2024
Q1 		$9.82K Sell
1,023
-565
-36% -$6.55K ﹤0.01% 3205
2023
Q4 		$13.2K Sell
1,588
-12,635
-89% -$73.4K ﹤0.01% 3178
2023
Q3 		$119K Buy
14,223
+2,732
+24% +$23.2K ﹤0.01% 2810
2023
Q2 		$106K Buy
11,491
+7,253
+171% +$81.3K ﹤0.01% 2828
2023
Q1 		$58.2K Buy
4,238
+190
+5% +$3.93K ﹤0.01% 2851
2022
Q4 		$68.9K Buy
4,048
+399
+11% +$7.98K ﹤0.01% 2891
2022
Q3 		$83K Buy
3,649
+435
+14% +$8.78K ﹤0.01% 2866
2022
Q2 		$58K Buy
3,214
+367
+13% +$6.54K ﹤0.01% 2979
2022
Q1 		$76K Hold
2,847
– – ﹤0.01% 2927
2021
Q4 		$84K Hold
2,847
– – ﹤0.01% 2945
2021
Q3 		$186K Buy
2,847
+1,511
+113% +$116K ﹤0.01% 2715
2021
Q2 		$112K Buy
1,336
+188
+16% +$13.9K ﹤0.01% 2695
2021
Q1 		$88K Buy
1,148
+12
+1% +$1.09K ﹤0.01% 2651
2020
Q4 		$100K Sell
1,136
-40
-3% -$2.81K ﹤0.01% 2588
2020
Q3 		$87K Sell
1,176
-306
-21% -$18.1K ﹤0.01% 2527
2020
Q2 		$109K Buy
1,482
+681
+85% +$41.4K ﹤0.01% 2502
2020
Q1 		$43K Sell
801
-182
-19% -$7.98K ﹤0.01% 2643
2019
Q4 		$37K Buy
+983
New +$24.7K ﹤0.01% 2942

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Legal & General Group's IGMS Position: Q2 2025 in Review

Legal & General Group sold out of IGM Biosciences (IGMS) in Q2 2025, closing a stake of 1,746 shares — an estimated $2.02K sold.

Legal & General Group first reported a position in IGMS in Q4 2019 and held it in 22 quarters. The position peaked at $186K in Q3 2021. 66 funds tracked by Wall St. Rank hold IGMS as of Q2 2025.

  • Legal & General Group reported no remaining IGM Biosciences position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 1,746 IGM Biosciences shares in Q2 2025, an estimated $2.02K.
  • Legal & General Group first reported a position in IGM Biosciences in Q4 2019 and held it in 22 quarters.
  • Legal & General Group's IGM Biosciences position peaked at $186K in Q3 2021.
  • 66 funds tracked by Wall St. Rank held IGM Biosciences as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.